Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Provider Licenses & Credentials

MadeMed is committed to transparency regarding our provider qualifications and licensure. We partner with licensed healthcare professionals who meet the highest standards of care and maintain active licenses in the states where they practice telemedicine.

Dr. Thai Minh Pham, MD


Board-Certified Internal Medicine Physician

Dr. Pham leads MadeMed's medical approach with over 20 years of experience in patient care. A graduate of Brown University with both a medical degree and a bachelor's degree in computer science, Dr. Pham combines clinical expertise with technological innovation to create personalized telehealth solutions.

Active Medical Licenses


- California Medical Board: C 199334
  Valid through: December 31, 2026
Verification Link
- Massachusetts Board of Registration in Medicine: 152422
Verification Link
- Rhode Island Board of Medical Licensure: MD20230
Verification Link
- Vermont Board of Medical Practice: 042.0018113-COMP
Verification Link

Board Certification


- American Board of Internal Medicine (ABIM)
  Certified since: October 1, 1998
  Expiration: April 1, 2025

Education & Training


- Doctor of Medicine, Brown University (1995)
- Bachelor of Science, Brown University
- Residency: Baystate Medical Center (Internal Medicine) - Completed 1998

State Telehealth Requirements


MadeMed complies with all state regulations regarding telehealth practice. In accordance with telehealth laws in California (Cal. Bus. & Prof. Code § 680.5(e)), Massachusetts (Mass. Board of Registration in Medicine Policy 15-05), Rhode Island (R.I. Board of Medical Licensure and Discipline Telemedicine Guidelines), and Vermont (Vt. Board of Medical Practice Policy on Telemedicine), we provide this licensure information publicly to ensure transparency.

For questions about our providers or telehealth services, please contact us.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.